Singapore markets close in 4 hours 52 minutes

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
5.41+0.02 (+0.37%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 61.97M
Enterprise value 38.45M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.62
Price/book (mrq)2.19
Enterprise value/revenue 3.51
Enterprise value/EBITDA -6.00

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-21.76%
S&P500 52-week change 322.64%
52-week high 38.90
52-week low 34.22
50-day moving average 35.24
200-day moving average 35.73

Share statistics

Avg vol (3-month) 37.24k
Avg vol (10-day) 35.35k
Shares outstanding 511.45M
Implied shares outstanding 611.45M
Float 87.82M
% held by insiders 110.16%
% held by institutions 112.23%
Shares short (28 Mar 2024) 410.83k
Short ratio (28 Mar 2024) 41.29
Short % of float (28 Mar 2024) 40.14%
Short % of shares outstanding (28 Mar 2024) 40.09%
Shares short (prior month 29 Feb 2024) 49.36k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 Nov 2016
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -64.05%
Operating margin (ttm)-1,694.98%

Management effectiveness

Return on assets (ttm)-13.06%
Return on equity (ttm)-23.16%

Income statement

Revenue (ttm)10.96M
Revenue per share (ttm)0.96
Quarterly revenue growth (yoy)415.50%
Gross profit (ttm)N/A
EBITDA -6.41M
Net income avi to common (ttm)-7.02M
Diluted EPS (ttm)-0.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.67M
Total cash per share (mrq)2.33
Total debt (mrq)3.16M
Total debt/equity (mrq)11.15%
Current ratio (mrq)8.62
Book value per share (mrq)2.47

Cash flow statement

Operating cash flow (ttm)-2.76M
Levered free cash flow (ttm)-1.9M